342 related articles for article (PubMed ID: 24175986)
21. [Iron overload in sickle cell anemia : a study of 94 patients].
Hafsia R; Belakhal F; Ben Salah N; Gouider E; Elborgi W
Tunis Med; 2011 Jun; 89(6):548-52. PubMed ID: 21681718
[TBL] [Abstract][Full Text] [Related]
22. Cardiac iron overload in sickle-cell disease.
Meloni A; Puliyel M; Pepe A; Berdoukas V; Coates TD; Wood JC
Am J Hematol; 2014 Jul; 89(7):678-83. PubMed ID: 24664847
[TBL] [Abstract][Full Text] [Related]
23. Assessment of cardiac iron deposition in sickle cell disease using 3.0 Tesla cardiovascular magnetic resonance.
Ibrahim el-SH; Rana FN; Johnson KR; White RD
Hemoglobin; 2012; 36(4):343-61. PubMed ID: 22563880
[TBL] [Abstract][Full Text] [Related]
24. Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease.
Ballas SK
Semin Hematol; 2001 Jan; 38(1 Suppl 1):30-6. PubMed ID: 11206959
[TBL] [Abstract][Full Text] [Related]
25. Chronically transfused pediatric sickle cell patients are protected from cardiac iron overload.
Kaushik N; Eckrich MJ; Parra D; Yang E
Pediatr Hematol Oncol; 2012 Apr; 29(3):254-60. PubMed ID: 22303979
[TBL] [Abstract][Full Text] [Related]
26. Deferiprone as an oral iron chelator in sickle cell disease.
Voskaridou E; Douskou M; Terpos E; Stamoulakatou A; Meletis J; Ourailidis A; Papassotiriou I; Loukopoulos D
Ann Hematol; 2005 Jul; 84(7):434-40. PubMed ID: 15809885
[TBL] [Abstract][Full Text] [Related]
27. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients.
Christoforidis A; Haritandi A; Tsitouridis I; Tsatra I; Tsantali H; Karyda S; Dimitriadis AS; Athanassiou-Metaxa M
J Pediatr Hematol Oncol; 2006 May; 28(5):311-5. PubMed ID: 16772883
[TBL] [Abstract][Full Text] [Related]
28. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
[TBL] [Abstract][Full Text] [Related]
29. Spin density projection-assisted R2 magnetic resonance imaging of the liver in the management of body iron stores in patients receiving multiple red blood cell transfusions: an audit and retrospective study in South Australia.
Brown GC; Patton WN; Tapp HE; Taylor DJ; St Pierre TG
Intern Med J; 2012 Sep; 42(9):990-6. PubMed ID: 22647084
[TBL] [Abstract][Full Text] [Related]
30. T2* MRI in regularly transfused children with thalassemia intermedia: serum ferritin does not reflect liver iron stores.
Tony S; Daar S; Elshinawy M; Al-Zadjaly S; Al-Khabori M; Wali Y
Pediatr Hematol Oncol; 2012 Sep; 29(6):579-84. PubMed ID: 22839111
[TBL] [Abstract][Full Text] [Related]
31. Consequences and management of iron overload in sickle cell disease.
Porter J; Garbowski M
Hematology Am Soc Hematol Educ Program; 2013; 2013():447-56. PubMed ID: 24319218
[TBL] [Abstract][Full Text] [Related]
32. Iron stores assessment in alcoholic liver disease.
Costa Matos L; Batista P; Monteiro N; Ribeiro J; Cipriano MA; Henriques P; Girão F; Carvalho A
Scand J Gastroenterol; 2013 Jun; 48(6):712-8. PubMed ID: 23534461
[TBL] [Abstract][Full Text] [Related]
33. Correlation between liver iron concentration determined by magnetic resonance imaging and serum ferritin in adolescents with thalassaemia disease.
Chuansumrit A; Laothamathat J; Sirachainan N; Sungkarat W; Wongwerawattanakoon P; Kumkrua P
Paediatr Int Child Health; 2016 Aug; 36(3):203-8. PubMed ID: 27595699
[TBL] [Abstract][Full Text] [Related]
34. High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors.
Majhail NS; DeFor T; Lazarus HM; Burns LJ
Biol Blood Marrow Transplant; 2008 Jul; 14(7):790-4. PubMed ID: 18541198
[TBL] [Abstract][Full Text] [Related]
35. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
[TBL] [Abstract][Full Text] [Related]
36. Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.
Kolnagou A; Yazman D; Economides C; Eracleous E; Kontoghiorghes GJ
Hemoglobin; 2009; 33(5):312-22. PubMed ID: 19814677
[TBL] [Abstract][Full Text] [Related]
37. Reassessment of Iron Biomarkers for Prediction of Dialysis Iron Overload: An MRI Study.
Rostoker G; Griuncelli M; Loridon C; Magna T; Machado G; Drahi G; Dahan H; Janklewicz P; Cohen Y
PLoS One; 2015; 10(7):e0132006. PubMed ID: 26182077
[TBL] [Abstract][Full Text] [Related]
38. Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury.
Adamkiewicz TV; Abboud MR; Paley C; Olivieri N; Kirby-Allen M; Vichinsky E; Casella JF; Alvarez OA; Barredo JC; Lee MT; Iyer RV; Kutlar A; McKie KM; McKie V; Odo N; Gee B; Kwiatkowski JL; Woods GM; Coates T; Wang W; Adams RJ
Blood; 2009 Nov; 114(21):4632-8. PubMed ID: 19721013
[TBL] [Abstract][Full Text] [Related]
39. Iron overload in adults with sickle cell disease who have received intermittent red blood cell transfusions.
Pack-Mabien A; Brown B; Herbert DE; Haynes J
J Am Assoc Nurse Pract; 2015 Oct; 27(10):591-6. PubMed ID: 25711464
[TBL] [Abstract][Full Text] [Related]
40. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A
Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
